Location History:
- Westfield, NJ (US) (1994)
- Scotch Plains, NJ (US) (1993 - 1996)
- Highlands, NJ (US) (2001 - 2003)
- Holmdel, NJ (US) (2007)
Company Filing History:
Years Active: 1993-2007
Title: The Innovative Contributions of Scott D. Feighner
Introduction
Scott D. Feighner, residing in Scotch Plains, NJ, has made significant strides in the field of biomedical research through his innovative contributions. With a total of 11 patents to his name, he has focused on the cloning and identification of various receptors that play critical roles in gastrointestinal health and growth hormone regulation.
Latest Patents
Among his most notable recent inventions are two patents concerning the motilin receptor and growth hormone secretagogue receptors. The first patent details the cloning and identification of the motilin receptor. This receptor has been isolated and cloned, with nucleic acid sequences provided. Feighner identified two splice variants of the motilin receptor, and the patent also outlines assays for potential ligands. The identification of the cloned motilin receptor opens avenues for screening compounds that may assist in treating various gastric conditions, particularly gastric motility disorders.
His second patent focuses on the growth hormone secretagogue receptor family, wherein human, swine, and rat receptors have been isolated, cloned, and sequenced. These receptors are identified as new members of the G-protein family. The implications of this research are profound, particularly for developing therapies for conditions linked to growth hormone deficiencies, such as in children or elderly patients experiencing musculoskeletal issues due to aging or recovery from fractures.
Career Highlights
Currently, Scott D. Feighner is associated with Merck & Company, Inc., a global leader in pharmaceuticals and healthcare. His role at Merck allows him to further explore and develop his innovative ideas, contributing to advancements in medical science.
Collaborations
Throughout his career, Feighner has worked alongside accomplished colleagues including Paul A. Liberator and Prasanta R. Chakraborty. These collaborations have proven valuable, as they combine expertise from diverse backgrounds to enhance the quality and impact of their research efforts.
Conclusion
Scott D. Feighner exemplifies the spirit of innovation within the medical research community. His contributions, particularly in understanding and utilizing receptors that impact gastric health and growth hormone regulation, mark him as a prominent figure in the field. As he continues his work with Merck, his patents hold the promise of bringing new therapies to light, potentially transforming the lives of many individuals facing health challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.